The VOX system is an automated breath sampling and analyzing system designed for the rapid detection of volatiles organic compounds associated with pathogens and cancerogenic in breath, including the coronavirus. Using a sample of the subject’s breath and analyzing it using an advance Ion Mobility Spectrometer (IMS) the system detects whether the biomarkers for s specific pathogen are present and outputs accurate test results. The test is groundbreaking and designed to be accurate, fast, provide on-the-spot results, non-invasive, and to detect patients in all stages of the disease, including asymptomatic patients. At this stage, the company is carrying out a final validation clinical trial and is in the process of commercializing the product.